Search - tctmd.com

Displaying 121 - 140 of 243

Sort: Relevancy | Date

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Conference News ESC 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Michael O'Riordan

August 30, 2021

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Conference News EAS 2021

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Michael O'Riordan

June 07, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Daily News

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

Michael O'Riordan

June 02, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

Shelley Wood

December 31, 2020

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood

December 23, 2020

Advertisement

Could an App Replace Statin Prescribing by Doctors?

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

OMT Boosts Survival in Revascularized Patients at 10 Years

Statins Not Linked to Dementia or Memory Changes: ASPREE

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

TCTMD’s Top 10 Most Popular Stories for March 2021

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

FDA Approves Evinacumab for Rare Homozygous FH

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

TCTMD’s Top 10 Most Popular Stories for December 2020

The Biggest News of 2020: TCTMD’s Top 10

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content